Smr Ophthalmic Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-05-2024
- Paid Up Capital ₹ 0.10 M
as on 15-05-2024
- Company Age 29 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 95.32%
(FY 2022)
- Profit 375.08%
(FY 2022)
- Ebitda 255.20%
(FY 2022)
- Net Worth 61.30%
(FY 2022)
- Total Assets 22.88%
(FY 2022)
About Smr Ophthalmic
The Company is engaged in the Fashion And Accessories Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Snehlata Aroskar, Ajit Ghadi, Swapnil Shirodkar, and One other member serve as directors at the Company.
- CIN/LLPIN
U33115MH1995PTC088125
- Company No.
088125
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 May 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Smr Ophthalmic Private Limited offer?
Smr Ophthalmic Private Limited offers a wide range of products and services, including Lenses, Gonio Lenses, Human Anatomical Models, Eye Model, Eye Testing Machines, Ophthalmic Equipment, Autoclaves, Sterilizers & Incubators, Hospital Autoclave & Sterilizers, Disposable & Other Optical Lenses, Optical Components.
Who are the key members and board of directors at Smr Ophthalmic?
Board Members(4)
Financial Performance and Corporate Structure Insights of Smr Ophthalmic.
Smr Ophthalmic Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 95.32% increase. The company also saw a substantial improvement in profitability, with a 375.08% increase in profit. The company's net worth Soared by an impressive increase of 61.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Smr Ophthalmic?
In 2019, Smr Ophthalmic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Smr Innovations Private Limited
Active
24 years 7 months Snehlata Aroskar, Swapnil Shirodkar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Smr Ophthalmic?
Smr Ophthalmic has a workforce of 7 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Smr Ophthalmic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smr Ophthalmic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
